» Articles » PMID: 33711204

B-cell Capacity for Differentiation Changes with Age

Overview
Journal Aging Cell
Specialties Cell Biology
Geriatrics
Date 2021 Mar 12
PMID 33711204
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Age-related immune deficiencies are thought to be responsible for increased susceptibility to infection in older adults, with alterations in lymphocyte populations becoming more prevalent over time. The loss of humoral immunity in ageing was attributed to the diminished numbers of B cells and the reduced ability to generate immunoglobulin.

Aims: To compare the intrinsic B-cell capacity for differentiation into mature plasma cells (PCs), between young and old donors, using in vitro assays, providing either effective T-cell help or activation via TLR engagement.

Methods: B cells were isolated from healthy individuals, in younger (30-38 years) and older (60-64 years) donors. An in vitro model system of B-cell differentiation was used, analysing 5 differentiation markers by flow cytometry, under T-dependent (TD: CD40/BCR stimulation) or T-independent (TI: TLR7/BCR activation) conditions. Antibody secretion was measured by ELISA and gene expression using qPCR.

Results: TI and TD differentiation resulted in effective proliferation of B cells followed by their differentiation into PC. B-cell-executed TI differentiation was faster, all differentiation marker and genes being expressed earlier than under TD differentiation (day 6), although generating less viable cells and lower antibody levels (day 13). Age-related differences in B-cell capacity for differentiation were minimal in TD differentiation. In contrast, in TI differentiation age significantly affected proliferation, viability, differentiation, antibody secretion and gene expression, older donors being more efficient.

Conclusion: Altogether, B-cell differentiation into PC appeared similar between age groups when provided with T-cell help, in contrast to TI differentiation, where multiple age-related changes suggest better capacities in older donors. These new findings may help explain the emergence of autoantibodies in ageing.

Citing Articles

How aging influences the gut-bone marrow axis and alters hematopoietic stem cell regulation.

Wells C, Robertson T, Sheth P, Abraham S Heliyon. 2024; 10(12):e32831.

PMID: 38984298 PMC: 11231543. DOI: 10.1016/j.heliyon.2024.e32831.


Tobacco exposure, but not aging, shifts the frequency of peripheral blood B cell subpopulations.

Pinto T, da Silva C, Pinto R, Duarte A, Benard G, Fernandes J Geroscience. 2023; 46(2):2729-2738.

PMID: 38157147 PMC: 10828235. DOI: 10.1007/s11357-023-01051-6.


Metabolic Reprogramming During B-Cell Differentiation.

Stephenson S, Doody G Methods Mol Biol. 2023; 2675:271-283.

PMID: 37258770 DOI: 10.1007/978-1-0716-3247-5_20.


How aging impacts vaccine efficacy: known molecular and cellular mechanisms and future directions.

Chen J, Deng J, Goldstein D Trends Mol Med. 2022; 28(12):1100-1111.

PMID: 36216643 PMC: 9691569. DOI: 10.1016/j.molmed.2022.09.008.


CD11b B Cells Increase after Stroke and Regulate Microglia.

Korf J, Honarpisheh P, Mohan E, Banerjee A, Blasco-Conesa M, Honarpisheh P J Immunol. 2022; 209(2):288-300.

PMID: 35732342 PMC: 9446461. DOI: 10.4049/jimmunol.2100884.


References
1.
Moura R, Quaresma C, Vieira A, Goncalves M, Polido-Pereira J, Romao V . B-cell phenotype and IgD-CD27- memory B cells are affected by TNF-inhibitors and tocilizumab treatment in rheumatoid arthritis. PLoS One. 2017; 12(9):e0182927. PMC: 5590747. DOI: 10.1371/journal.pone.0182927. View

2.
Goronzy J, Fang F, Cavanagh M, Qi Q, Weyand C . Naive T cell maintenance and function in human aging. J Immunol. 2015; 194(9):4073-80. PMC: 4452284. DOI: 10.4049/jimmunol.1500046. View

3.
Kennedy D, Knight K . Inflammatory Changes in Bone Marrow Microenvironment Associated with Declining B Lymphopoiesis. J Immunol. 2017; 198(9):3471-3479. PMC: 5435233. DOI: 10.4049/jimmunol.1601643. View

4.
Vikstrom I, Slomp A, Carrington E, Moesbergen L, Chang C, Kelly G . MCL-1 is required throughout B-cell development and its loss sensitizes specific B-cell subsets to inhibition of BCL-2 or BCL-XL. Cell Death Dis. 2016; 7(8):e2345. PMC: 5108322. DOI: 10.1038/cddis.2016.237. View

5.
Peperzak V, Vikstrom I, Walker J, Glaser S, LePage M, Coquery C . Mcl-1 is essential for the survival of plasma cells. Nat Immunol. 2013; 14(3):290-7. PMC: 4041127. DOI: 10.1038/ni.2527. View